Skip to main content

Advertisement

SpringerLink
Log in

Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis

  • Review
  • Published:
Tumor Biology

Abstract

Leptin is a multifunctional adipose-derived cytokine that plays a critical role in bodyweight homeostasis and energy balance. Plasma level of leptin is an indicator of the amount of energy stored in adipose tissues. Recently, leptin and leptin receptor dysregulation have been reported in a variety of malignant cells including colorectal cancers (CRCs). There are growing evidence that leptin may be the link between obesity and CRC carcinogenesis. Leptin influence the growth and proliferation of cancer cells via activation of various growth and survival signaling pathways including JAK/STAT, PI3-kinase/AKT, and/or MAP kinases. In this review, current understanding of leptin and its receptor’s roles in the pathogenesis of colonogenic cancer has been described.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, Ob-R. Cell. 1995;83:1263–71.

    Article  CAS  PubMed  Google Scholar 

  2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–32.

    Article  CAS  PubMed  Google Scholar 

  3. Gorska E, Popko K, Stelmaszczyk-Emmel A, Ciepiela O, Kucharska A, Wasik M. Leptin receptors. Eur J Med Res. 2010;15 Suppl 2:50–4.

    PubMed  Google Scholar 

  4. Jung CH, Kim MS. Molecular mechanisms of central leptin resistance in obesity. Arch Pharm Res. 2013;36:201–7.

    Article  CAS  PubMed  Google Scholar 

  5. Tong Q, Xu Y. Central leptin regulation of obesity and fertility. Curr Obes Rep. 2012;1:236–44.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Guffey CR, Fan D, Singh UP, Murphy EA. Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms. Curr Opin Clin Nutr Metab Care. 2013;16:595–600.

    Article  CAS  PubMed  Google Scholar 

  7. Ogden CL, Carroll MD, Kit BK, Flegal KM. prevalence of obesity and trends in body mass index among us children and adolescents, 1999–2010. JAMA, J Am Med Assoc. 2012;307:483–90.

    Article  Google Scholar 

  8. Sun Z, Dragon S, Becker A, Gounni AS. Leptin inhibits neutrophil apoptosis in children via erk/nf-kappab-dependent pathways. PloS one. 2013;8:e55249.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Sheffield L. Malignant transformation of mammary epithelial cells increases expression of leptin and leptin receptor. Endocr Res. 2008;33:111–8.

    Article  CAS  PubMed  Google Scholar 

  10. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. American Cancer S: cancer statistics, 2004. CA Cancer J Clin. 2004;54:8–29.

    Article  PubMed  Google Scholar 

  11. Golan T, Urban D, Berger R, Lawrence YR. Changing prognosis of metastatic colorectal adenocarcinoma: differential improvement by age and tumor location. Cancer. 2013;119:3084–91.

    Article  PubMed  Google Scholar 

  12. Boeing H. Obesity and cancer–the update 2013. Best Pract Res Clin Endocrinol Metab. 2013;27:219–27.

    Article  PubMed  Google Scholar 

  13. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62:933–47.

    Article  CAS  PubMed  Google Scholar 

  14. Terry PD, Miller AB, Rohan TE. Obesity and colorectal cancer risk in women. Gut. 2002;51:191–4.

    Article  CAS  PubMed  Google Scholar 

  15. Stattin P, Lukanova A, Biessy C, Soderberg S, Palmqvist R, Kaaks R, et al. Obesity and colon cancer: does leptin provide a link? Int J Cancer. 2004;109:149–52.

    Article  CAS  PubMed  Google Scholar 

  16. Sinicrope FA, Foster NR, Sargent DJ, O’Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res. 2010;16:1884–93.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Bray GA. Medical consequences of obesity. J Clin Cancer Endocrinol Metab. 2004;89:2583–9.

    Article  CAS  Google Scholar 

  18. Liefers SC, te Pas MF, Veerkamp RF, van der Lende T. Associations between leptin gene polymorphisms and production, live weight, energy balance, feed intake, and fertility in holstein heifers. J Dairy Sci. 2002;85:1633–8.

    Article  CAS  PubMed  Google Scholar 

  19. Gribovskaja-Rupp I, Kosinski L, Ludwig KA. Obesity and colorectal cancer. Clin Colon Rectal Surg. 2011;24:229–43.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Gonullu G, Kahraman H, Bedir A, Bektas A, Yucel I. Association between adiponectin, resistin, insulin resistance, and colorectal tumors. Int J Colorectal Dis. 2010;25:205–12.

    Article  PubMed  Google Scholar 

  21. Erkasap N, Ozkurt M, Erkasap S, Yasar F, Uzuner K, Ihtiyar E, et al. Leptin receptor (Ob-R) mRNA expression and serum leptin concentration in patients with colorectal and metastatic colorectal cancer. Braz J Med Biol Res. 2013;46:306–10.

    Article  CAS  PubMed  Google Scholar 

  22. Tutino V, Notarnicola M, Guerra V, Lorusso D, Caruso MG. Increased soluble leptin receptor levels are associated with advanced tumor stage in colorectal cancer patients. Anticancer Res. 2011;31:3381–3.

    CAS  PubMed  Google Scholar 

  23. Song M, Zhang X, Wu K, Ogino S, Fuchs CS, Giovannucci EL, Chan AT. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study. Cancer Prev Res 2013

  24. Paik SS, Jang SM, Jang KS, Lee KH, Choi D, Jang SJ. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Ann Surg Oncol. 2009;16:297–303.

    Article  PubMed  Google Scholar 

  25. Abolhassani M, Aloulou N, Chaumette MT, Aparicio T, Martin-Garcia N, Mansour H, et al. Leptin receptor-related immune response in colorectal tumors: the role of colonocytes and interleukin-8. Cancer Res. 2008;68:9423–32.

    Article  CAS  PubMed  Google Scholar 

  26. Aloulou N, Bastuji-Garin S, Le Gouvello S, Abolhassani M, Chaumette MT, Charachon A, et al. Involvement of the leptin receptor in the immune response in intestinal cancer. Cancer Res. 2008;68:9413–22.

    Article  CAS  PubMed  Google Scholar 

  27. Koda M, Sulkowska M, Kanczuga-Koda L, Surmacz E, Sulkowski S. Overexpression of the obesity hormone leptin in human colorectal cancer. J Clin Pathol. 2007;60:902–6.

    Article  PubMed  Google Scholar 

  28. Fenton JI, Lavigne JA, Perkins SN, Liu H, Chandramouli GV, Shih JH, et al. Microarray analysis reveals that leptin induces autocrine/paracrine cascades to promote survival and proliferation of colon epithelial cells in an apc genotype-dependent fashion. Mol Carcinog. 2008;47:9–21.

    Article  CAS  PubMed  Google Scholar 

  29. Fenton JI, Hursting SD, Perkins SN, Hord NG. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an apc (min/+) colon epithelial cell line. Carcinogenesis. 2006;27:1507–15.

    Article  CAS  PubMed  Google Scholar 

  30. FitzGerald AJ, Mandir N, Goodlad RA. Leptin, cell proliferation and crypt fission in the gastrointestinal tract of intravenously fed rats. Cell Prolif. 2005;38:25–33.

    Article  CAS  PubMed  Google Scholar 

  31. Uddin S, Bavi PP, Hussain AR, Alsbeih G, Al-Sanea N, Abduljabbar A, et al. Leptin receptor expression in middle eastern colorectal cancer and its potential clinical implication. Carcinogenesis. 2009;30:1832–40.

    Article  CAS  PubMed  Google Scholar 

  32. Janeckova R. The role of leptin in human physiology and pathophysiology. Physiol Res Acad Sci Bohemoslov. 2001;50:443–59.

    CAS  Google Scholar 

  33. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. New Engl J Med. 1996;334:292–5.

    Article  CAS  PubMed  Google Scholar 

  34. Liu L, Zhong R, Wei S, Xiang H, Chen J, Xie D, et al. The leptin gene family and colorectal cancer: interaction with smoking behavior and family history of cancer. PLoS ONE. 2013;8:e60777.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250–2.

    Article  CAS  PubMed  Google Scholar 

  36. Chua Jr SC, Chung WK, Wu-Peng XS, Zhang Y, Liu SM, Tartaglia L, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science. 1996;271:994–6.

    Article  CAS  PubMed  Google Scholar 

  37. Ahima RS, Flier JS. Leptin. Ann Rev Physiol. 2000;62:413–37.

    Article  CAS  Google Scholar 

  38. Lin J, Barb CR, Matteri RL, Kraeling RR, Chen X, Meinersmann RJ, et al. Long form leptin receptor mRNA expression in the brain, pituitary, and other tissues in the pig. Dom Animal Endocrinol. 2000;19:53–61.

    Article  CAS  Google Scholar 

  39. Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A. Leptin in reproduction. Trends Endocrinol Metabol TEM. 2001;12:65–72.

    Article  CAS  Google Scholar 

  40. Bartucci M, Svensson S, Ricci-Vitiani L, Dattilo R, Biffoni M, Signore M, et al. Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells. Endocrine Rel Cancer. 2010;17:823–33.

    Article  CAS  Google Scholar 

  41. Birmingham JM, Busik JV, Hansen-Smith FM, Fenton JI. Novel mechanism for obesity-induced colon cancer progression. Carcinogenesis. 2009;30:690–7.

    Article  CAS  PubMed  Google Scholar 

  42. Amemori S, Ootani A, Aoki S, Fujise T, Shimoda R, Kakimoto T, et al. Adipocytes and preadipocytes promote the proliferation of colon cancer cells in vitro. Am J Physiol Gastrointest Liver Physiol. 2007;292:G923–9.

    Article  CAS  PubMed  Google Scholar 

  43. Saxena NK, Sharma D, Ding X, Lin S, Marra F, Merlin D, et al. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells. Cancer Res. 2007;67:2497–507.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Huang XF, Chen JZ. Obesity, the PI3K/AKT signal pathway and colon cancer. Obes Rev. 2009;10:610–16.

    Article  CAS  PubMed  Google Scholar 

  45. Ogunwobi OO, Beales IL. Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells. Dig Dis Sci. 2007;52:1934–45.

    Article  CAS  PubMed  Google Scholar 

  46. Bjorbaek C, Uotani S, da Silva B, Flier JS. Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem. 1997;272:32686–95.

    Article  CAS  PubMed  Google Scholar 

  47. Sharma D, Saxena NK, Vertino PM, Anania FA. Leptin promotes the proliferative response and invasiveness in human endometrial cancer cells by activating multiple signal-transduction pathways. Endocrine Rel Cancer. 2006;13:629–40.

    Article  CAS  Google Scholar 

  48. Deo DD, Rao AP, Bose SS, Ouhtit A, Baliga SB, Rao SA, et al. Differential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells. J Biomed Biotechnol. 2008;2008:163902.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Gao J, Tian J, Lv Y, Shi F, Kong F, Shi H, et al. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells. Cancer Sci. 2009;100:389–95.

    Article  CAS  PubMed  Google Scholar 

  50. Beales IL, Ogunwobi OO. Leptin synergistically enhances the anti-apoptotic and growth-promoting effects of acid in oe33 oesophageal adenocarcinoma cells in culture. Mol Cell Endocrinol. 2007;274:60–8.

    Article  CAS  PubMed  Google Scholar 

  51. Quintas-Cardama A, Verstovsek S. Molecular pathways: JAK/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res. 2013;19:1933–40.

    Article  CAS  PubMed  Google Scholar 

  52. Yu JH, Kim H. Role of Janus kinase/signal transducers and activators of transcription in the pathogenesis of pancreatitis and pancreatic cancer. Gut Liver. 2012;6:417–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  53. Singh N, Hussain S, Bharadwaj M, Kakkar N, Singh SK, Sobti RC. Overexpression of signal transducer and activator of transcription (stat-3 and stat-5) transcription factors and alteration of suppressor of cytokine signaling (socs-1) protein in prostate cancer. J Recept Signal Transduct Res. 2012;32:321–27.

    Article  CAS  PubMed  Google Scholar 

  54. Ma XT, Wang S, Ye YJ, Du RY, Cui ZR, Somsouk M. Constitutive activation of STAT3 signaling pathway in human colorectal carcinoma. World J Gastroentorol WJG. 2004;10:1569–73.

    CAS  Google Scholar 

  55. Osaki LH, Gama P. Mapks and signal transduction in the control of gastrointestinal epithelial cell proliferation and differentiation. Int J Mol Sci. 2013;14:10143–61.

    Article  PubMed Central  PubMed  Google Scholar 

  56. Taylor CA, Zheng Q, Liu Z, Thompson JE. Role of p38 and jnk mapk signaling pathways and tumor suppressor p53 on induction of apoptosis in response to ad-eif5a1 in a549 lung cancer cells. Mol Cancer. 2013;12:35.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Weston CR, Lambright DG, Davis RJ. Signal transduction. MAP kinase signaling specificity. Science. 2002;296:2345–7.

    Article  CAS  PubMed  Google Scholar 

  58. Hegyi K, Fulop K, Kovacs K, Toth S, Falus A. Leptin-induced signal transduction pathways. Cell Biol Int. 2004;28:159–69.

    Article  CAS  PubMed  Google Scholar 

  59. van den Brink GR, O’Toole T, Hardwick JC, van den Boogaardt DE, Versteeg HH, van Deventer SJ, et al. Leptin signaling in human peripheral blood mononuclear cells, activation of p38 and p42/44 mitogen-activated protein (map) kinase and p70 s6 kinase. Mol Cell Biol Res Comm MCBRC. 2000;4:144–50.

    Article  Google Scholar 

  60. Dreyer MG, Juge-Aubry CE, Gabay C, Lang U, Rohner-Jeanrenaud F, Dayer JM, et al. Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa b/pu.1 binding site. Biochem J. 2003;370:591–9.

    Article  CAS  PubMed  Google Scholar 

  61. Ogunwobi O, Mutungi G, Beales IL. Leptin stimulates proliferation and inhibits apoptosis in barrett’s esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-e2-mediated transactivation of the epidermal growth factor receptor and c-jun nh2-terminal kinase activation. Endocrinology. 2006;147:4505–16.

    Article  CAS  PubMed  Google Scholar 

  62. Sun Y, Sinicrope FA. Selective inhibitors of mek1/erk44/42 and p38 mitogen-activated protein kinases potentiate apoptosis induction by sulindac sulfide in human colon carcinoma cells. Mol Cancer Ther. 2005;4:51–9.

    CAS  PubMed  Google Scholar 

  63. Nishihara H, Hwang M, Kizaka-Kondoh S, Eckmann L, Insel PA. Cyclic amp promotes camp-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through erk1/2 and p38 mapk. J Biol Chem. 2004;279:26176–83.

    Article  CAS  PubMed  Google Scholar 

  64. Chan UP, Lee JF, Wang SH, Leung KL, Chen GG. Induction of colon cancer cell death by 7-hydroxystaurosporine (ucn-01) is associated with increased p38 mapk and decreased bcl-xl. Anti Canc Drugs. 2003;14:761–6.

    Article  CAS  Google Scholar 

  65. Lee EJ, Park HG, Kang HS. Sodium salicylate induces apoptosis in hct116 colorectal cancer cells through activation of p38mapk. Int J Oncol. 2003;23:503–8.

    CAS  PubMed  Google Scholar 

  66. Hussain AR, Ahmed SO, Ahmed M, Khan OS, Al Abdulmohsen S, Platanias LC, et al. Cross-talk between nfkb and the PI3-kinase/AKT pathway can be targeted in primary effusion lymphoma (pel) cell lines for efficient apoptosis. PLoS ONE. 2012;7:e39945.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  67. Li W, Wang H, Kuang CY, Zhu JK, Yu Y, Qin ZX, et al. An essential role for the id1/pi3k/akt/nfkb/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem. 2012;363:135–45.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene. 1999;18:6938–47.

    Article  CAS  PubMed  Google Scholar 

  69. Carpenter CL, Duckworth BC, Auger KR, Cohen B, Schaffhausen BS, Cantley LC. Purification and characterization of phosphoinositide 3-kinase from rat liver. J Biol Chem. 1990;265:19704–11.

    CAS  PubMed  Google Scholar 

  70. Chen HC, Guan JL. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1994;91:10148–52.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655–57.

    Article  CAS  PubMed  Google Scholar 

  72. Jiang BH, Aoki M, Zheng JZ, Li J, Vogt PK. Myogenic signaling of phosphatidylinositol 3-kinase requires the serine-threonine kinase akt/protein kinase b. Proc Natl Acad Sci U S A. 1999;96:2077–81.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Uddin S, Bu R, Ahmed M, Abubaker J, Al-Dayel F, Bavi P, et al. Overexpression of leptin receptor predicts an unfavorable outcome in middle eastern ovarian cancer. Mol Cancer. 2009;8:74.

    Article  PubMed Central  PubMed  Google Scholar 

  74. Uddin S, Bavi P, Siraj AK, Ahmed M, Al-Rasheed M, Hussain AR, et al. Leptin-r and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. Endocrine Rel Cancer. 2010;17:191–202.

    Article  CAS  Google Scholar 

  75. Wang D, Chen J, Chen H, Duan Z, Xu Q, Wei M, et al. Leptin regulates proliferation and apoptosis of colorectal carcinoma through PI3K/AKT/mTOR signalling pathway. J Biosci. 2012;37:91–101.

    Article  PubMed  Google Scholar 

  76. Rao CV, Janakiram NB, Mohammed A. Lipoxygenase and cyclooxygenase pathways and colorectal cancer prevention. Curr Colorectal Cancer Rep. 2012;8:316–24.

    Article  PubMed Central  PubMed  Google Scholar 

  77. Muller-Decker K. Cyclooxygenase-dependent signaling is causally linked to non-melanoma skin carcinogenesis: pharmacological, genetic, and clinical evidence. Canc Metastasis Rev. 2011;30:343–61.

    Article  Google Scholar 

  78. Liu CH, Chang SH, Narko K, Trifan OC, Wu MT, Smith E, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem. 2001;276:18563–69.

    Article  CAS  PubMed  Google Scholar 

  79. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998;93:705–16.

    Article  CAS  PubMed  Google Scholar 

  80. Perlikos F, Harrington KJ, Syrigos KN. Key molecular mechanisms in lung cancer invasion and metastasis: a comprehensive review. Crit Rev Oncol Hematol. 2013;87:1–11.

    Article  PubMed  Google Scholar 

  81. Bhave SL, Teknos TN, Pan Q. Molecular parameters of head and neck cancer metastasis. Crit Rev Eukaryot Gen Expr. 21:143–53.

  82. Salzmann S, Seher A, Trebing J, Weisenberger D, Rosenthal A, Siegmund D, et al. Fibroblast growth factor inducible (fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity. J Biol Chem. 2013;288:13455–66.

    Article  CAS  PubMed  Google Scholar 

  83. Sarfstein R, Werner H. Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction. Endocrinology. 2013;154:1672–79.

    Article  CAS  PubMed  Google Scholar 

  84. Chan CM, Chang HH, Wang VC, Huang CL, Hung CF. Inhibitory effects of resveratrol on pdgf-bb-induced retinal pigment epithelial cell migration via pdgfrbeta, pi3k/akt and mapk pathways. PloS ONE. 2013;8:e56819.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  85. Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G, et al. Plasma leptin and colorectal cancer risk: a prospective study in northern sweden. Oncol Rep. 2003;10:2015–21.

    PubMed  Google Scholar 

  86. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281:1683–6.

    Article  CAS  PubMed  Google Scholar 

  87. Hardwick JC, Van Den Brink GR, Offerhaus GJ, Van Deventer SJ, Peppelenbosch MP. Leptin is a growth factor for colonic epithelial cells. Gastroenterology. 2001;121:79–90.

    Article  CAS  PubMed  Google Scholar 

  88. Attoub S, Noe V, Pirola L, Bruyneel E, Chastre E, Mareel M, et al. Leptin promotes invasiveness of kidney and colonic epithelial cells via phosphoinositide 3-kinase-, rho-, and rac-dependent signaling pathways. FASEB J. 2000;14:2329–38.

    Article  CAS  PubMed  Google Scholar 

  89. Liu Z, Uesaka T, Watanabe H, Kato N. High fat diet enhances colonic cell proliferation and carcinogenesis in rats by elevating serum leptin. Int J Oncol. 2001;19:1009–14.

    CAS  PubMed  Google Scholar 

  90. Fox SB, Gasparini G, Harris AL. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol. 2001;2:278–89.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Human Cancer Genomic Research, Research Center, King Faisal Specialist Hospital and Research Center, MBC#98-16, P.O. Box 3354, Riyadh, 11211, Saudi Arabia

    Shahab Uddin, Azhar R. Hussain & Khawla S. Al-Kuraya

  2. Benedictine University, Lisle, IL, USA

    Omar S. Khan

Authors
  1. Shahab Uddin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azhar R. Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Omar S. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Khawla S. Al-Kuraya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shahab Uddin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uddin, S., Hussain, A.R., Khan, O.S. et al. Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis. Tumor Biol. 35, 871–879 (2014). https://doi.org/10.1007/s13277-013-1166-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1166-4

Keywords

Search

Navigation